Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06500780 · ClinicalTrials.gov registry record · NA
Equipping Patients Using Interventions for Pain and Depression
A NA study of Depression and Chronic Pain, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 304
- Enrollment target
- 1
- Study location
NCT06500780 is a NA study of Depression and Chronic Pain that is actively recruiting participants, run by Indiana University. The registered enrollment target is 304 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06500780, a NA study of Depression and Chronic Pain, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 304 participants
- Enrollment target
- 1
- Study location
Study Summary
This project is part of the NIH Helping to End Addiction Long-term (HEAL) initiative (https://heal.nih.gov/). This randomized controlled trial (RCT) is phase 2 of a two-phase, 5-year project with the overarching goal of testing a decision aid (DA)/coaching intervention, tailored to Black patients with comorbid chronic pain and depression, to encourage use of and adherence to nonpharmacological pain treatments (NPTs). This 2-arm trial will randomize 304 patients with comorbid chronic musculoskeletal pain and depression in primary care from an urban safety-net health system (Eskenazi). After the baseline assessment, patients randomized to the intervention will be asked to participate in 4 coaching sessions over approximately 12 weeks. Sessions will use Motivational Interviewing principles to foster openness to NPTs and self-efficacy by helping patients identify their goals and priorities, understand their NPT options, prepare them to discuss and choose options with their primary care providers (PCPs), and reinforce these choices to foster maintenance of these changes. DA contents will be integrated into these sessions, which will facilitate discussion of these options with their PCP. The first 3 sessions take place prior to the patient's next scheduled PCP visit; the final session occurs after this visit. Assessments will be conducted at baseline, 3 months (i.e., after completing the final coaching session), and 6 months. Patients randomized to the wait-list control group will receive usual care (in addition to study assessments at baseline, 3 months, and 6 months). After completing the final assessment, they will then be given the DA and offered a 20-minute coaching session to walk them through it.
Conditions Studied
Interventions
- BEHAVIORAL Coaching and Decision Aid
Study Locations (1)
Indiana
- Eskenazi Health Primary Care - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2024-08-13 |
| Est. Completion | 2027-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06500780
The ClinicalTrials.gov registry entry for NCT06500780 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (61% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Coaching and Decision Aid is the first listed.
NCT06500780 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT06500780 about?
NCT06500780 is a clinical study titled "Equipping Patients Using Interventions for Pain and Depression". This project is part of the NIH Helping to End Addiction Long-term (HEAL) initiative (https://heal.nih.gov/). This randomized controlled trial (RCT) is phase 2 of a two-phase, 5-year project with the overarching goal of testing a decision aid (DA)/coaching intervention, tailored to Black patients wi...
What is the current status of trial NCT06500780?
This trial is currently recruiting. It is a NA study. The enrollment target is 304 participants. The study started on 2024-08-13. Estimated completion is 2027-05-31.
What conditions does trial NCT06500780 study?
This clinical trial studies the following conditions: Depression, Chronic Pain, Musculoskeletal Pain, Health Equity.
What interventions are being tested in trial NCT06500780?
The interventions under investigation include: Coaching and Decision Aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT06500780?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06500780 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.